The latest price target for Surmodics (NASDAQ:SRDX) was reported by Needham on November 7, 2024. The analyst firm set a price target for $0.00 expecting SRDX to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Surmodics (NASDAQ:SRDX) was provided by Needham, and Surmodics reiterated their hold rating.

The last upgrade for Surmodics Inc happened on June 13, 2023 when Needham raised their price target to $36. Needham previously had a hold for Surmodics Inc.

The last downgrade for Surmodics Inc happened on May 30, 2024 when Barrington Research changed their price target from N/A to N/A for Surmodics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surmodics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surmodics was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.

While ratings are subjective and will change, the latest Surmodics (SRDX) rating was a reiterated with a price target of $0.00 to $0.00. The current price Surmodics (SRDX) is trading at is $39.75, which is out of the analyst’s predicted range.